Lappe Mark
Director
CIK: 1366074
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 1,500 | $98.88 | $148,320.45 | View Details Filing |
| Sep 28, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 3,000 | $101.70 | $305,106.00 | View Details Filing |
| Sep 25, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 3,324 | $98.87 | $328,630.25 | View Details Filing |
| Sep 25, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 2,176 | $99.60 | $216,726.99 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 1,219 | $111.88 | $136,382.33 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 5,895 | $99.29 | $585,342.85 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 9,681 | $112.28 | $1,087,001.07 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 6,605 | $100.64 | $664,719.27 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 1,100 | $107.12 | $117,836.29 | View Details Filing |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | P | 500 | $108.23 | $54,117.50 | View Details Filing |